Company intelligence / Profile preview

Jordan E. Pollack

Tel Aviv, Tel Aviv District, Israeldnb.com ↗

Ownership: Private
Development stage: Other

Overview

VeinWay has developed Traversa, a dedicated tool for crossing chronic venous occlusions. The product has been used in first-in-human compassionate use cases and aims to address the needs of patients with post-thrombotic syndrome and chronic deep vein blockages[4]. Clinical results are early but promising in restoring blood flow where previous interventions failed.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Boston ScientificSheba Medical CenterMEDX Ventures GroupConsensus Business Group (CBG)West Pharmaceuticals

Beyond the preview

Go deeper on Jordan E. Pollack.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jordan E. Pollack.

Explore the full profile